Chronix Biomedical designs and produces blood tests using single nucleotide polymorphisms or SNPs technology for the detection and monitoring of all stages of chronic disease — from the early symptom-free stage to the disease treatment and monitoring stages. Chronix’s diagnostic test kits are being developed for use on standard high throughput laboratory instruments.

For information contact:
John DiPietro
CFO
US Number: +1 408-960-2306